Identification of crystals within mucus that contain the protein galectin‐10 (Gal10) acts as an adjuvant for Type 2 immunity, thereby increasing inflammation, but antibodies specific for Gal10 dissolved these crystals and ameliorated disease symptoms in a humanized mouse model of asthma [48]. This evidence concerns the gene CLC and asthma.